Outcomes of Pediatric Precursor B Cell Acute Lymphoblastic Leukemia: A Tertiary Care Cancer Center Experience from a Lower-Middle-Income Country
References
- Sampagar A, Patil G, Reddy NA, Dias M. ALL induction outcome: real-world data from a pediatric oncology centre in an LMIC setup with rural predominance. Indian J Cancer. 2024;61(2):215–223. doi:10.4103/ijc.ijc_355_21.
- Gupta S, Hunger SP. Recent trends in the results of studies conducted by the Children’s Oncology Group acute lymphoblastic leukemia committee and implications for emerging cooperative trial groups in low- and middle-income countries. Pediatr Hematol Oncol J. 2020;5(4):151–155. doi:10.1016/j.phoj.2020.03.001.
- Arora RS, Arora B. Acute leukemia in children: a review of the current Indian data. South Asian J Cancer. 2016;5(3):155–160. doi:10.4103/2278-330X.187591.
- Thakkar D, Upasana K, Udayakumar DS, Rastogi N, Chadha R, Arora S, et al. Treatment of pediatric acute lymphoblastic leukemia in India as per modified BFM-95 protocol with minimal residual disease monitoring. Hematology. 2025;30(1). doi:10.1080/16078454.2024.2439733.
- Alejandro G, Lewis BS. Acute lymphoblastic leukemia. In: Orkin SH, Fisher DE, Ginsburg D, Look AT, Lux SE, Nathan DG, editors. Nathan and Oski’s Hematology and Oncology of Infancy and Childhood. 8th ed. Philadelphia: Elsevier; 2015. p. 1527–1554.
- Children’s Cancer Trials Team. UKALL 2011 protocol. Version 3.0. Birmingham (UK): Cancer Research UK Clinical Trials Unit, University of Birmingham; 2013 Oct 1. Available from:
https://www.northerncanceralliance.nhs.uk/wp-content/uploads/2019/01/UKALL2011-Protocol-v3.0-01-Oct-2013.pdf - Children’s Cancer and Leukaemia Group. UKALL 2019 interim guidelines. Version 1.1. Leicester (UK): Children’s Cancer and Leukaemia Group; 2019 Aug.
- Carroll WL, Bhojwani D. Acute lymphoblastic leukemia. In: Lanzkowsky P, Lipton JM, Fish JD, editors. Lanzkowsky’s Manual of Pediatric Hematology and Oncology. 6th ed. Philadelphia: Elsevier; 2016. p. 367–389.
- Hu Y, Liu Y, Fu J, Liu Y, Wang H, Song Y. Global, regional, and national burden of acute lymphoblastic leukemia in children: epidemiological trends analysis from 1990 to 2021. iScience. 2024;27(12):111356. doi:10.1016/j.isci.2024.111356.
- Amjad A, Wali RM, Anjum S, Mansoor R. A single institution’s experience with cytogenetic and minimal residual disease outcomes in pediatric acute lymphoblastic leukemia. J Coll Physicians Surg Pak. 2019;29(6):549–552. doi:10.29271/jcpsp.2019.06.549.
- Vora A, Goulden N, Wade R, Mitchell C, Hancock J, Hough R, et al. Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): a randomised controlled trial. Lancet Oncol. 2013;14(3):199–209. doi:10.1016/S1470-2045(12)70600-9
- Ahmed AM, Al-Trabolsi H, Bayoumy M, Abosoudah I, Yassin F. Improved outcomes of childhood acute lymphoblastic leukemia: a retrospective single-center study in Saudi Arabia. Asian Pac J Cancer Prev. 2019;20(11):3391–3398. doi:10.31557/APJCP.2019.20.11.3391.
- Ahmad I, Ghafoor T, Ullah A, Naz S, Tahir M, Ahmed S, et al. Pediatric acute lymphoblastic leukemia: clinical characteristics, treatment outcomes, and prognostic factors: 10 years’ experience from a low- and middle-income country. JCO Glob Oncol. 2023;9:e2200288. doi:10.1200/GO.22.00288.
- Duffy C, Graetz DE, Lopez AMZ, Carrillo AK, Job G, Chen Y, et al. Retrospective analysis of outcomes for pediatric acute lymphoblastic leukemia in South American centers. Front Oncol. 2023;13:1254233. doi:10.3389/fonc.2023.1254233.
- Gogoi MP, Das P, Das N, Das S, Narula G, Trehan A, et al. Risk stratified treatment for childhood acute lymphoblastic leukaemia: a multicentre observational study from India. Lancet Reg Health Southeast Asia. 2025;37:100593. doi:10.1016/j.lansea.2025.100593.
- Ramadhan MH, Sari NM, Peryoga SU, Susanah S. Survival and treatment outcomes of childhood acute lymphoblastic leukemia in a low-middle income country: a single-center experience in West Java, Indonesia. J Blood Med. 2024;15:77–85. doi:10.2147/JBM.S438042.
- O’Connor D, Bonney D, Cummins M, van Delft F, Ghorashian S, Halsey C, et al. UK relapsed ALL guideline. Version 1.2. Leicester (UK): Children’s Cancer and Leukaemia Group (CCLG); 2021 Nov.
- Ward ZJ, Yeh JM, Bhakta N, Frazier AL, Girardi F, Atun R. Global childhood cancer survival estimates and priority-setting: a simulation-based analysis. Lancet Oncol. 2019;20(7):972–983. doi:10.1016/S1470-2045(19)30273-6.
- Fadoo Z, Nisar I, Yousuf F, Lakhani LS, Ashraf S, Imam U, et al. Clinical features and induction outcome of childhood acute lymphoblastic leukemia in a lower/middle income population: a multi-institutional report from Pakistan. Pediatr Blood Cancer. 2015;62(10):1700–1708. doi:10.1002/pbc.25583.
- Nisar I, Shahid S, Yousuf F, Lakhani LS, Ashraf S, Imam U, et al. Treatment outcomes and prognostic factors of childhood acute lymphoblastic leukemia in a low-middle income population: a multi-institutional report from Pakistan. Pediatr Blood Cancer. 2023;70(2):e29889. doi:10.1002/pbc.29889.
- Siddiqui DE, Ashraf MS, Iftikhar S, Belgaumi AF. Predictors of treatment abandonment for patients with pediatric cancer at Indus Children Cancer Hospital, Karachi, Pakistan. Pediatr Blood Cancer. 2018;65(2):e26818. doi:10.1002/pbc.26818.
DOI: https://doi.org/10.2478/jcas-2026-0017 | Journal eISSN: 2411-989X
Language: English
Page range: 129 - 135
Published on: Sep 10, 2026
Published by: Shakuat Khanum Memorial Cancer Hospital and Research Centre
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
Related subjects:
© 2026 Naeem Akram Butt, Najma Shaheen, Irfana Ishaq Sindhu, Amina Anwar, Saba Sattar, Hafiz Muhammad Mubashir Waheed, Hiba Asif, Ammarah Tahir, Aqeela Rashid, published by Shakuat Khanum Memorial Cancer Hospital and Research Centre
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.